From Acerinox to Tubacex: Companies were prepared to avoid the tariff’s coup
Donald Trump He has stirred the map of the world economy again. On this occasion the focus has been put ...
Tag: acerinox
The Trump rate to steel and aluminum puts 500 million exports at risk, but it benefits Acerinox
Donald Trump's threat to recover 25% tariffs on the importation of steel and aluminum to the United States puts up ...
The Ibex steel companies separate at the start of 2025: Acerinox rises 4.6% and ArcelorMittal loses 5%
The Ibex 35 steel companies start the year on opposing paths. While Acerinox advances 4.6% since the first of January, ...
CaixaBank BPI recommends buying Acerinox for the first time in three years
For the first in the last three years, CaixaBank BPI believes that it is a good time to put Acerinox ...
IAG and Acerinox reap double-digit rebounds this month
With only one session left to conclude the penultimate month of the year on the stock market, Spanish equities can ...
Acerinox obtains the last authorization to buy the American Haynes
The Spanish stainless steel company Acerinox has reported that the Austrian competition authorities have approved the purchase of the American ...
Acerinox recovers 10% in the week thanks to the Republican victory
Although this week full of volatility in the stock markets has been bearish for the Spanish market, some companies have ...
Acerinox earns 53% less until September weighed down by weak demand and the effects of the strike in Cádiz
Acerinox, the Spanish multinational dedicated to the manufacture of stainless steel, obtained an attributable profit (the profit that is directly ...
Popular News
-
Ignaz Semmelweis, the doctor who ended up in the asylum for insisting on washing his hands
-
Trump’s economic chaos actually hides a plan to cause a recession
-
Laurence leaves Spain this Wednesday, but the rain does not cease: much of the country faces a new Borrascas train
-
In a hygienic and safe way: How to clean your dental splint well
-
Officials ask the government to investigate whether there are pressures not to prescribe expensive drugs against cancer
